Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-002906

Options or other derivatives

  • Chief Executive Officer acquired 520,342 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2026-01-07 Grant or award · Stock Option (Right to Buy) +520,342 520,342 D: show line 1 in the form
Loading xslF345X05/ownership.xml…